We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEMI
5901
DELISTED
Chembio diagnostics, Inc.
CEMI
$122K ﹤0.01%
26,814
-79
-0.3% -$385
LJPC
5902
DELISTED
La Jolla Pharmaceutical Company
LJPC
$122K ﹤0.01%
30,972
+18,690
+152% +$110K
DOMO icon
5903
Domo
DOMO
$184M
$121K ﹤0.01%
5,589
-53,934
-91% -$996K
DQ
5904
Daqo New Energy
DQ
$996M
$121K ﹤0.01%
11,805
+7,265
+160% +$61.8K
GAIA icon
5905
Gaia
GAIA
$48.4M
$121K ﹤0.01%
15,221
+7,176
+89% +$55.5K
ASTH icon
5906
Astrana Health
ASTH
$1.77B
$121K ﹤0.01%
6,596
-7,368
-53% -$122K
DEX
5907
DELISTED
DELAWARE ENHANCED GLOBAL DIVIDEND & INCOME FUND
DEX
$121K ﹤0.01%
11,610
-44,142
-79% -$442K
QGTA
5908
DELISTED
IQ Leaders GTAA Tracker ETF
QGTA
$121K ﹤0.01%
4,770
+1,706
+56% +$42.2K
EPAC icon
5909
Enerpac Tool Group
EPAC
$1.93B
$120K ﹤0.01%
4,632
-18,571
-80% -$453K
KALA icon
5910
KALA BIO
KALA
$14.5M
$119K ﹤0.01%
13
+7
+117% +$67.6K
NATR icon
5911
Nature's Sunshine
NATR
$288M
$119K ﹤0.01%
13,342
+5,873
+79% +$55.1K
FEUL
5912
DELISTED
Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ
FEUL
$119K ﹤0.01%
1,141
-196
-15% -$19K
ADMS
5913
DELISTED
Adamas Pharmaceuticals
ADMS
$119K ﹤0.01%
31,459
+17,638
+128% +$84.4K
DNI
5914
DELISTED
Dividend and Income Fund
DNI
$119K ﹤0.01%
8,840
+959
+12% +$11.9K
NJV
5915
DELISTED
Nuveen New Jersey Municipal Value Fund Common shares of beneficial interest
NJV
$119K ﹤0.01%
8,537
-4,036
-32% -$55.7K
BPT
5916
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$118K ﹤0.01%
17,149
+2,244
+15% +$16.6K
MIRM icon
5917
Mirum Pharmaceuticals
MIRM
$6.14B
$118K ﹤0.01%
4,817
+1,229
+34% +$13.1K
PBPB
5918
DELISTED
Potbelly
PBPB
$118K ﹤0.01%
27,979
+13,520
+94% +$59K
PSNL icon
5919
Personalis
PSNL
$1.51B
$118K ﹤0.01%
10,865
+4,977
+85% +$51.8K
LMT icon
5920
PUT
Lockheed Martin
LMT
$136B
$117K ﹤0.01%
300
MRKR icon
5921
Marker Therapeutics
MRKR
$18.7M
$117K ﹤0.01%
4,054
+1,720
+74% +$62.6K
PLBC icon
5922
Plumas Bancorp
PLBC
$429M
$117K ﹤0.01%
4,449
+849
+24% +$20K
GLV
5923
Clough Global Dividend & Income Fund
GLV
$78.1M
$116K ﹤0.01%
10,668
-5,320
-33% -$58.3K
GMAB icon
5924
Genmab
GMAB
$19.5B
$116K ﹤0.01%
5,190
+537
+12% +$11.7K
VBFC
5925
DELISTED
Village Bank and Trust Financial Corp.
VBFC
$116K ﹤0.01%
3,129
+169
+6% +$6.03K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.